However, myeloma cells have reduced ADCC activity due to downregulated expression of NK cell receptors, such as natural killer group 2D (NKG2D), NKp30, CD244, and DNAX accessory molecule 1 (DNAM-1) [37,38]. Here, CD226 is linked to plasma cell myeloma.